232 related articles for article (PubMed ID: 19710033)
21. INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease.
Arora A; Kumar A; Prasad N; Duseja A; Acharya SK; Agarwal SK; Aggarwal R; Anand AC; Bhalla AK; Choudhary NS; Chawla YK; Dhiman RK; Dixit VK; Gopalakrishnan N; Gupta A; Hegde UN; Jasuja S; Jha V; Kher V; Kumar A; Madan K; Maiwall R; Mathur RP; Nayak SL; Pandey G; Pandey R; Puri P; Rai RR; Raju SB; Rana DS; Rao PN; Rathi M; Saraswat VA; Saxena S; Shalimar ; Sharma P; Singh SP; Singal AK; Soin AS; Taneja S; Varughese S
J Clin Exp Hepatol; 2021; 11(3):354-386. PubMed ID: 33994718
[TBL] [Abstract][Full Text] [Related]
22. Hepatorenal Syndrome.
Kiser TH
Int J Clin Med; 2014 Jan; 5(3):102-110. PubMed ID: 32284909
[TBL] [Abstract][Full Text] [Related]
23. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.
Velez JCQ; Therapondos G; Juncos LA
Nat Rev Nephrol; 2020 Mar; 16(3):137-155. PubMed ID: 31723234
[TBL] [Abstract][Full Text] [Related]
24. Chinese guidelines on the management of ascites and its related complications in cirrhosis.
; Xu X; Duan Z; Ding H; Li W; Jia J; Wei L; Linghu E; Zhuang H
Hepatol Int; 2019 Jan; 13(1):1-21. PubMed ID: 30656520
[TBL] [Abstract][Full Text] [Related]
25. Artificial liver support systems: what is new over the last decade?
García Martínez JJ; Bendjelid K
Ann Intensive Care; 2018 Nov; 8(1):109. PubMed ID: 30443736
[TBL] [Abstract][Full Text] [Related]
26. KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.
Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol; 2018 Sep; 24(3):230-277. PubMed ID: 29991196
[No Abstract] [Full Text] [Related]
27. Hepatorenal syndrome: Update on diagnosis and therapy.
Acevedo JG; Cramp ME
World J Hepatol; 2017 Feb; 9(6):293-299. PubMed ID: 28293378
[TBL] [Abstract][Full Text] [Related]
28. Liver dialysis in acute-on-chronic liver failure: current and future perspectives.
Maiwall R; Maras JS; Nayak SL; Sarin SK
Hepatol Int; 2014 Sep; 8 Suppl 2():505-13. PubMed ID: 26201332
[TBL] [Abstract][Full Text] [Related]
29. Treatment to improve acute kidney injury in cirrhosis.
Wong F
Curr Treat Options Gastroenterol; 2015 Jun; 13(2):235-48. PubMed ID: 25773606
[TBL] [Abstract][Full Text] [Related]
30. Renal dysfunction in cirrhosis.
Urrunaga NH; Mindikoglu AL; Rockey DC
Curr Opin Gastroenterol; 2015 May; 31(3):215-23. PubMed ID: 25763790
[TBL] [Abstract][Full Text] [Related]
31. Hepatorenal syndrome: aetiology, diagnosis, and treatment.
Low G; Alexander GJ; Lomas DJ
Gastroenterol Res Pract; 2015; 2015():207012. PubMed ID: 25649410
[TBL] [Abstract][Full Text] [Related]
32. Optimal management of hepatorenal syndrome in patients with cirrhosis.
Angeli P; Morando F
Hepat Med; 2010 Jun; 2():87-98. PubMed ID: 24367209
[TBL] [Abstract][Full Text] [Related]
33. MARS therapy, the bridging to liver retransplantation - Three cases from the Hungarian liver transplant program.
Pőcze B; Fazakas J; Zádori G; Görög D; Kóbori L; Dabasi E; Mándli T; Piros L; Smudla A; Szabó T; Toronyi E; Tóth S; Tőzsér G; Végső G; Doros A; Nemes B
Interv Med Appl Sci; 2013 Jun; 5(2):70-5. PubMed ID: 24265893
[TBL] [Abstract][Full Text] [Related]
34. Liver support systems: will they ever reach prime time?
Bañares R; Catalina MV; Vaquero J
Curr Gastroenterol Rep; 2013 Mar; 15(3):312. PubMed ID: 23392862
[TBL] [Abstract][Full Text] [Related]
35. Blood cytokine, chemokine and gene expression in cholestasis patients with intractable pruritis treated with a molecular adsorbent recirculating system: a case series.
Lisboa LF; Asthana S; Kremer A; Swain M; Bagshaw SM; Gibney N; Karvellas CJ
Can J Gastroenterol; 2012 Nov; 26(11):799-805. PubMed ID: 23166903
[TBL] [Abstract][Full Text] [Related]
36. Kidneys in chronic liver diseases.
Hartleb M; Gutkowski K
World J Gastroenterol; 2012 Jun; 18(24):3035-49. PubMed ID: 22791939
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in our understanding of hepatorenal syndrome.
Wong F
Nat Rev Gastroenterol Hepatol; 2012 May; 9(7):382-91. PubMed ID: 22614754
[TBL] [Abstract][Full Text] [Related]
38. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.
Nadim MK; Kellum JA; Davenport A; Wong F; Davis C; Pannu N; Tolwani A; Bellomo R; Genyk YS;
Crit Care; 2012 Feb; 16(1):R23. PubMed ID: 22322077
[TBL] [Abstract][Full Text] [Related]
39. Management of renal failure and ascites in patients with cirrhosis.
Madan K; Mehta A
Int J Hepatol; 2011; 2011():790232. PubMed ID: 21994871
[TBL] [Abstract][Full Text] [Related]
40. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
